You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Rybelsus

since 2025 › Mar › 29 (Sat) @ 18:51 UTC

auto-detected in 5 stories

35 days ago

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds ⊖

found 2026 › Mar › 10 (Tue) @ 22:57 UTC

a story from The Guardian ⚠️ › International

‘Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author

Patients taking Wegovy have nearly five times the risk of sudden sight loss o…

10 months ago

Ozempic has ‘very rare’ sight loss side effect, EU drugs regulator finds ○

found 2025 › Jun › 06 (Fri) @ 12:50 UTC

a story from Politico EU ✅ › Politico EU

The EMA’s drug safety committee launched a review of medicines containing semaglutide — the active ingredient in Ozempic, Wegovy and Rybelsus — in January.

12 months ago

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years ○

found 2025 › Mar › 30 (Sun) @ 08:50 UTC

a story from CNBC ⚠️ › World News

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years ○

found 2025 › Mar › 29 (Sat) @ 18:48 UTC

a story from CNBC ⚠️ › US News

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years ○

found 2025 › Mar › 29 (Sat) @ 18:48 UTC

a story from CNBC ⚠️ › Top News

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.

page 1 of 1